Smad3 Monoclonal Antibody(8B5)

The protein encoded by this gene belongs to the SMAD, a family of proteins similar to the gene products of the Drosophila gene 'mothers against decapentaplegic' (Mad) and the C. elegans gene Sma. SMAD proteins are signal transducers and transcriptional modulators that mediate multiple signaling pathways. This protein functions as a transcriptional modulator activated by transforming growth factor-beta and is thought to play a role in the regulation of carcinogenesis.

The SMAD3 Monoclonal Antibody (8B5) is a highly specific and reliable tool for the detection and analysis of SMAD3 protein expression. This antibody is produced using advanced monoclonal antibody technology, ensuring exceptional quality and consistency.

SMAD3 is a critical transcription factor involved in the transforming growth factor-beta (TGF-β) signaling pathway, playing a crucial role in various cellular processes such as cell proliferation, differentiation, and apoptosis. The SMAD3 Monoclonal Antibody (8B5) specifically recognizes the SMAD3 protein, enabling precise and accurate detection of its expression levels in various biological samples.

This antibody has been extensively validated for its specificity and sensitivity in various applications, including Western blotting, immunohistochemistry, and immunofluorescence. It exhibits minimal cross-reactivity with other SMAD family members, ensuring reliable and specific results.

The SMAD3 Monoclonal Antibody (8B5) is supplied as a ready-to-use solution, eliminating the need for time-consuming and complex antibody preparation procedures. It is compatible with a wide range of experimental conditions and can be used in both research and clinical settings.

With its exceptional performance and reliability, the SMAD3 Monoclonal Antibody (8B5) is an indispensable tool for researchers and clinicians studying the TGF-β signaling pathway and its implications in various diseases and biological processes.